Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

469 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Systemic treatment of pancreatic cancer revisited.
Ducreux M, Seufferlein T, Van Laethem JL, Laurent-Puig P, Smolenschi C, Malka D, Boige V, Hollebecque A, Conroy T. Ducreux M, et al. Among authors: seufferlein t. Semin Oncol. 2019 Feb;46(1):28-38. doi: 10.1053/j.seminoncol.2018.12.003. Epub 2018 Dec 27. Semin Oncol. 2019. PMID: 30638624 Free article. Review.
Palliative treatment of pancreatic cancer.
von Wichert G, Seufferlein T, Adler G. von Wichert G, et al. Among authors: seufferlein t. J Dig Dis. 2008 Feb;9(1):1-7. doi: 10.1111/j.1443-9573.2007.00314.x. J Dig Dis. 2008. PMID: 18251787 Review.
Current oncological treatment of patients with pancreatic cancer in germany: results from a national survey on behalf of the Arbeitsgemeinschaft Internistische Onkologie and the Chirurgische Arbeitsgemeinschaft Onkologie of the Germany Cancer Society.
Boeck S, Bruns CJ, Sargent M, Schafer C, Seufferlein T, Jauch KW, Heinemann V. Boeck S, et al. Among authors: seufferlein t. Oncology. 2009;77(1):40-8. doi: 10.1159/000226110. Epub 2009 Jun 25. Oncology. 2009. PMID: 19556808
Smarter drugs emerging in pancreatic cancer therapy.
Kleger A, Perkhofer L, Seufferlein T. Kleger A, et al. Among authors: seufferlein t. Ann Oncol. 2014 Jul;25(7):1260-1270. doi: 10.1093/annonc/mdu013. Epub 2014 Mar 14. Ann Oncol. 2014. PMID: 24631947 Free article. Review.
Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial.
Malka D, Cervera P, Foulon S, Trarbach T, de la Fouchardière C, Boucher E, Fartoux L, Faivre S, Blanc JF, Viret F, Assenat E, Seufferlein T, Herrmann T, Grenier J, Hammel P, Dollinger M, André T, Hahn P, Heinemann V, Rousseau V, Ducreux M, Pignon JP, Wendum D, Rosmorduc O, Greten TF; BINGO investigators. Malka D, et al. Among authors: seufferlein t. Lancet Oncol. 2014 Jul;15(8):819-28. doi: 10.1016/S1470-2045(14)70212-8. Epub 2014 May 19. Lancet Oncol. 2014. PMID: 24852116 Free PMC article. Clinical Trial.
[Therapy in pancreatic cancer - and still it moves along!].
Ettrich TJ, Perkhofer L, Seufferlein T. Ettrich TJ, et al. Among authors: seufferlein t. Dtsch Med Wochenschr. 2015 Apr;140(7):508-11. doi: 10.1055/s-0041-101154. Epub 2015 Mar 31. Dtsch Med Wochenschr. 2015. PMID: 25826035 German.
469 results